山东新华制药股份有限公司

投资者关系

信息透明，信任同行

2025-08-05

海外監管公告-關於子公司獲得非那雄胺片藥品註冊證書的公告

2025-08-04

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025

2025-08-04

截至二零二五年七月三十一日止月份之股份發行人的證券變動月報表

2025-07-15

海外監管公告-關於子公司產品獲得三類醫療器械註冊證的公告

2025-07-10

海外監管公告-2024年度A股派息實施公告

2025-07-02

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025

2025-07-02

截至二零二五年六月三十日止月份之股份發行人的證券變動月報表

2025-06-30

Overseas Regulatory Announcement-Announcement on Ivabradine Hydrochloride Tablets Having Obtained Drug Registration Certificate

2025-06-30

海外監管公告-關於獲得鹽酸伊伐佈雷定片藥品註冊證書的公告

2025-06-30

Overseas Regulatory Announcement-Announcement on Ibuprofen Arginine Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs